FTC's Winning Streak Restored: Seventh Circuit Reverses Denial of Preliminary Injunction in Chicago Hospital Merger, Competition News Volume 2016, Issue 1

by Pepper Hamilton LLP

Pepper Hamilton LLP

Recent appellate decisions confirm the uphill battle hospitals face when merging with other hospitals.

On October 31, the U.S. Court of Appeals for the Seventh Circuit overturned the district court’s ruling in Federal Trade Commission v. Advocate Health Care, No. 15-cv11473 (N.D. Ill. June 14, 2016). That decision found that the government had not properly defined the geographic area of competitive significance and, consequently, denied the FTC’s requested preliminary injunction of the merger of two Chicago-area hospital systems. However, the Seventh Circuit reversed and ordered the district court to reconsider its preliminary injunction ruling in light of the Seventh Circuit’s instructions and findings on the definition of a relevant geographic market.1

For almost a decade, the FTC successfully blocked the hospital mergers it challenged. Then, only one month before the Advocate district court decision, a Pennsylvania federal court was the first court since 20072 to rule against the FTC at the preliminary injunction stage in a case involving a merger of hospitals.3 The FTC appealed the Pennsylvania decision to the Third Circuit and won in late September.4 With the decision in Advocate, the Seventh Circuit followed suit by embracing the FTC’s market definition framework and reinstated the FTC’s winning streak.

The Facts and Proceedings

In September 2014, Advocate Health Care Network and NorthShore University HealthSystem entered into a strategic affiliation agreement. The Advocate health care system consists of 11 hospitals. More than two-thirds of Advocate’s revenues from commercial insurers (payers) come from risk-based contracts. The NorthShore health care system consists of four hospitals. Its commercial payer revenues are generated primarily through fee-for-service agreements.

A key touchstone of all antitrust counseling or advice is the goal or purpose of the client’s proposed conduct, whether that conduct is an acquisition or a loyalty discount program. Here, Advocate’s stated rationale for the merger is to develop “a new, lost-cost, high-performing network (HPN) insurance product” to be sold throughout the Chicago area. According to Advocate, it needs the NorthShore assets to offer an HPN product. NorthShore’s stated rationale is that the merger will permit it to “engage in large-scale full risk contracting,”5 which it is unable to do presently because it lacks sufficient geographic scope and utilization and care management tools that Advocate can offer.

The hospitals notified the FTC of the merger, and, after an investigation, the FTC issued an administrative complaint in December 2015, alleging that the merger may substantially lessen competition. Additionally, in February 2016, the FTC moved for a preliminary injunction in the Northern District of Illinois to prevent the hospital systems from closing the proposed transaction. After a multiday evidentiary hearing on the preliminary injunction motion, the court issued its ruling. The FTC appealed to the Seventh Circuit immediately, and the district court stayed the merger pending the appeal.

The District Court Decision

In deciding whether to grant a preliminary injunction, the district court was required to (1) determine the likelihood that the FTC will ultimately succeed on the merits and (2) balance the equities. The court concluded that the FTC failed to demonstrate that it would succeed on the merits.

To succeed on the merits, the FTC has to prove that the merger may substantially lessen competition in a relevant product and geographic market. In this case, the parties agreed on the product market — general acute care services sold to commercial payers and their insured members. However, the parties diverged on the geographic market in which to analyze the merger’s effects. The FTC’s expert argued that the geographic market should be limited to the “North Shore Area.” This area consists of six of the 15 merging hospitals as well as five additional hospitals not associated with the merging entities. All of these facilities are located in northern Cook County and southern Lake County. The FTC’s geographic market is based on the theory that patients want care from local providers and the location of the hospitals, and the market includes (1) local hospitals while excluding “destination hospitals,”6 (2) hospitals “with at least a two percent share in the area from which the relevant Advocate and NorthShore hospitals attract patients,” and (3) hospitals that draw patients from the same area as both Advocate and NorthShore rather than those that overlap with just one of the systems.

After defining the market, the FTC tested that geographic area using the “hypothetical monopolist test.” This test examines whether a hypothetical monopolist, which controlled all the hospitals in the alleged geographic market, could sustain a small but significant price increase (SSNIP) for services provided by the merging hospitals. An alleged geographic market passes the test if the hospitals located there are close enough substitutes that it would be profitable for the monopolist to impose that price increase. The FTC calculated the diversion ratio, or the percentage of patients that would switch to another hospital in the North Shore area for general acute services if their first choice were no longer available, to be 48 percent. According to the FTC’s economist, this intramarket diversion ratio, or substitution level, was sufficiently high to pass the hypothetical monopolist test.

The hospital systems, though, argued that the FTC’s geographic market definition was too narrowly drawn and that its definition arbitrarily excluded six destination hospitals and other facilities providing services in the Chicago area. Specifically, they argued that the market definition should include hospitals that are outside the North Shore area, but that are associated with doctor’s offices and outpatient facilities within the area and refer significant inpatient volume for general acute services hospitals outside the North Shore area. In support of this contention, the hospital systems used the FTC’s own diversion ratios to demonstrate that Northwestern Memorial Hospital, which is located outside the North Shore area, is the second or third choice for patients that use five of the six merging hospitals in the area.

The district court agreed with the hospital systems, concluding that the criteria used by the FTC to define the geographic market were flawed. The court noted that the FTC provided no economic basis for excluding “destination hospitals” from the geographic market. The court explained that the FTC merely assumed that these “destination hospitals” were not substitutes for Advocate and NorthShore because patients prefer to receive general acute care services closer to home. The court, however, found the testimony regarding customer preference ambiguous, with some witnesses agreeing that patients like to receive care closer to home (especially for more routine services) and other witnesses testifying that patients go to facilities closer to their jobs in the city. Further, the court noted that exclusion of “destination hospitals” from the relevant market ignored “commercial realities.” Commercial payers negotiate a single contract with a hospital system for both inpatient and outpatient care. These outpatient services are on the rise and impact where a patient chooses to receive inpatient care. The presence of doctors and outpatient facilities located in the North Shore area that are affiliated with hospitals outside of the North Shore area drive patients to these outside hospitals for inpatient services.

In addition, the court criticized the FTC economist’s third criterion, explaining that hospitals need not overlap with both Advocate and NorthShore in order to constrain pricing post-merger.

Citing the U.S. Supreme Court’s 1962 decision in Brown Shoe, 7 Judge Alonzo wrote, “There is no formula for determining the geographic market; rather it should be identified in a ‘pragmatic [and] factual’ way and should ‘correspond to the commercial realities of the industry.’” From this opinion, it appears that the court was focused on these “commercial realties” of the market more than the economic test presented by the FTC’s expert. For the above reasons, the court determined that the FTC failed to prove a relevant geographic market that conformed to the commercial realities of health care services in the Chicago area and, thus, denied the FTC’s preliminary injunction motion.

The Appeal

As noted above, a day after the district court’s decision, the FTC appealed to the Seventh Circuit Court of Appeals. The FTC then moved for, and the district court entered, an injunction to prevent the closing of the Advocate-NorthShore transaction pending appellate review.8

In its appeal, the FTC principally argued that the district court erred, as a matter of law, when it failed to take into consideration the results of the hypothetical monopolist, or SSNIP, test. It noted that both the FTC’s and hospitals’ experts agreed that the SSNIP test was the appropriate economic measure of the market definition. In addition, it pointed to court decisions that relied on the hypothetical monopolist test to define the geographic market in cases involving health care-related transactions.9 Accordingly, the FTC contended that the district court erred by focusing on patient rather than commercial payer preference and how the FTC’s geographic market was constructed, as opposed to whether the market passed the hypothetical monopolist test. Because the FTC’s geographic market passed the SSNIP test, it was properly defined.

In response, the hospitals first pointed out that the district court’s market definition decision is subject to deference on appeal, given that it is highly fact-specific and the result of a thorough examination of a voluminous record. In addition, they contended that the court’s opinion correctly determined that the FTC failed to provide evidentiary support for the crucial assumptions it made in constructing the geographic market and that the FTC’s request for an injunction pending appeal did not offer any facts to contradict the court’s conclusion that the FTC’s geographic market ignored commercial realities.

The Seventh Circuit Decision

In deciding to reverse and remand the district court’s opinion, the Seventh Circuit concluded that the lower court’s factual findings with respect to the relevant geographic market were clearly erroneous. The Seventh Circuit explained that the district court’s criticisms of the FTC’s alleged geographic market were incorrect in four ways: (1) overlooking the hypothetical monopolist test results of FTC’s expert and mistaking the test’s iterative process for logical circularity; (2) finding that the FTC lacked a basis for distinguishing local hospitals from academic centers; (3) determining that the evidence about patient preference for local hospitals was ambiguous; and (4) falling prey to the “silent majority” fallacy. The silent majority fallacy is the purportedly incorrect assumption that patients who travel a distance to obtain services constrain the price that hospitals charge to closer patients. This article will explain, in turn, each of these points below.

First, the Seventh Circuit concluded that the FTC correctly used an iterative process — known as the hypothetical monopolist test — to examine whether the proposed market was too narrow. Specifically, the FTC correctly proposed a candidate market, simulated monopolization of the market, adjusted the market if a hospital outside the candidate market could constrain the rates of the hypothetical monopolist in the candidate market, and reran the simulation as necessary. This was not circular, and, if the FTC’s candidate market were too narrow, the iterative testing of that market would reveal that it should be expanded.

Second, the Seventh Circuit did not find support for the district court’s determination that the FTC improperly excluded academic medical centers from the relevant geographic market. Witnesses consistently testified that the demand for academic facilities differed from demand for general acute care hospitals that draw patients from much smaller geographic areas. Both insurance company and hospital executives distinguished academic facilities from community hospitals by the complexity of services they offer. The Seventh Circuit found such testimony “an obvious and sound basis for distinguishing between academic medical centers and other hospitals like those operated by Advocate and NorthShore.”

Third, the Seventh Circuit rejected the district court’s finding that evidence of patient preference for short travel distance was equivocal. The Seventh Circuit determined that the district court incorrectly relied on testimony that work place locations and outpatient relationships influence patient choices and distinguished that testimony from testimony regarding patient hospital care preference. Based on the foregoing, the Seventh Circuit found strong evidence exists that 73 percent of patients living in the FTC’s proposed market receive hospital care there, 80 percent of those patients drive less than 15 miles or 20 minutes to their chosen hospital, and 95 percent drive 30 miles or less. Therefore, the evidence supported Dr. Tenn’s determination that patients generally chose hospitals close to their homes in establishing his candidate market.

Fourth and finally, the Seventh Circuit explained that the district court’s analysis incorrectly relied on certain diversion ratios — the percentage of patients who would choose a hospital outside the relevant market if their first choice was unavailable. Instead, the Seventh Circuit determined that “insurers are the most relevant buyers” of health care services, not the patients themselves. The Seventh Circuit noted that insurers consider whether employers would offer their plans and whether employees would sign up for those plans. Accordingly, diversion ratios or patient substitution measures “do not neatly translate into options for insurers.” The court found persuasive that insurance executives unanimously testified that an insurance network must include either an Advocate or NorthShore facility in the proposed geographic area to be marketable. As such, the hospitals have market power over the payers, which need these facilities to offer marketable products to customers that do not travel far to seek general acute care.

Lessons Learned

It remains to be seen exactly what the district court will do in light of the Seventh Circuit’s ruling and whether the hospitals will continue their fight through the long and expensive FTC administrative hearing process or abandon the merger. However, what is clear is that these recent appellate decisions confirm the uphill battle hospitals face when merging with other hospitals. As health care costs rise and hospital systems look to combine, these entities should assess the risk of a challenge by the FTC and consider the following:

  • Whether collaborations, short of merger, might achieve the same or similar efficiencies.
  • Proof of successful payer plans that do not include the merging parties or that payers were prepared to develop plans without them would be powerful evidence that the post-transaction system could not dictate rates.
  • When one of the merging hospitals is a “destination hospital,” the hospitals should consider whether there are any academic medical centers outside the candidate market to which patients go for inpatient care.





1 Fed. Trade Comm’n v. Advocate Health Care Network, No. 16-02492 (7th Cir. Oct. 31, 2016), available at http://media.ca7.uscourts.gov/cgi-bin/rssExec.pl?Submit=Display&Path=Y2016/D10-31/C:16-2492:J:Hamilton:aut:T:fnOp:N:1854909:S:0.

2 In re Evanston Nw. Healthcare, 2007 WL 2286195 (F.T.C. Aug. 6, 2007).

3 In Federal Trade Commission v. Penn State Hershey Medical Center, No. 1:15-cv-2362 (M.D. Pa. May 9, 2016), the Middle District of Pennsylvania denied the FTC’s motion to preliminarily enjoin the merger of Penn State Hershey Medical Center and Pinnacle Health System. For more on the decision, read our article, “A Sweet Win for Hershey Medical Center's Proposed Merger: District Court Denies FTC's Attempt to Block Pennsylvania Hospital Merger,” available at http://www.pepperlaw.com/publications/a-sweet-win-for-hershey-medical-centers-proposed-merger-district-court-denies-ftcs-attempt-to-block-pennsylvania-hospital-merger-2016-05-16/.

4 Fed. Trade Comm’n v. Penn State Hershey Med. Ctr., No. 16-2365 (3d. Cir. Sept. 27, 2016). For more on the Third Circuit’s opinion, read our article, “The End of the Road for Hershey Medical Center’s Merger: Parties Abandon Transaction After Third Circuit Rules That Hospital Merger Should Be Preliminarily Enjoined,” available at http://www.pepperlaw.com/publications/the-end-of-the-road-for-hershey-medical-centers-merger-parties-abandon-transaction-after-third-circuit-rules-that-hospital-merger-should-be-preliminarily-enjoined-2016-10-17/.

5 Risk contracting, also known as a shared savings arrangement, is based on an agreed-to benchmark spending level that a population is likely to incur. If the provider spends less than the benchmark, it will split the difference between the benchmark and the actual cost with the commercial insurance company.

6 “Destination hospitals” are those “that attract patients from throughout the Chicago metropolitan area, at long distances.” These hospitals include Northwestern Memorial Hospital, Rush University Hospital, University of Chicago Hospital, Loyola University Hospital, Cancer Treatment Centers of America and Lurie Children’s Hospital.

7 Brown Shoe Co. v. United States, 370 U.S. 294, 336-37 (1962).

8 Without an injunction, the merger could have closed as early as June 20, 2016.

9 Saint Alphonsus Med. Ctr.-Nampa Inc. v. St. Luke’s Health Sys., Ltd., 778 F.3d 775, 784-85 (9th Cir. 2015); FTC v. ProMedica Health Sys., Inc., 2011 WL 1219281, at *55 (N.D. Ohio Mar. 29, 2011).


Written by:

Pepper Hamilton LLP

Pepper Hamilton LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.